NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/29/2023
Back to search
Official data from USPTO
LUMABRIDGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/29/2023
Trademark type
Combined
Nice classes
35, 42, 45
Filing date
07/19/2022
Registration date
08/29/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2023
Last transaction
08/29/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/23/2022
First use in commerce
08/23/2022
Drawing code
3
Owner type
16
Owner location
SAN ANTONIO, TX
Examiner
LEVINE, HOWARD
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "LumaBridge" with a pattern of radiating lines forming a semi-circle over the last 5 letters of the word portion of the mark.
Holders and representatives
Holders
LUMABRIDGE, LLC
Clinical Research Insight, LLC
Representatives
Megan R. Bradshaw PIRKEY BARBER PLLC
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trialsproviding information management services; Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing business intelligence services in the fields of medical devices and pharmaceuticals
Class 42
Medical and scientific researchconducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the fields of oncologyimmunologymilitary medicineemergency medicinecritical careregenerative medicineinfectious disease; Consulting services for others in the field of designplanningimplementation project management of scientific research and clinical trials; Medical research; Scientific research and development; Biomedical research services; Providing information about medical and scientific research; Research and development of vaccines and medicines; Consulting services in the fields of biotechnology and pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines
Class 45
Regulatory compliance consulting in the field of prescription drug sampling
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/29/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/25/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/24/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/21/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/20/2023
IUAF
USE AMENDMENT FILED
05/25/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/25/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/28/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2022
PUBO
PUBLISHED FOR OPPOSITION
10/25/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/21/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/21/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/21/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/19/2022
GNRT
NON-FINAL ACTION E-MAILED
08/19/2022
CNRT
NON-FINAL ACTION WRITTEN
08/19/2022
DOCK
ASSIGNED TO EXAMINER
08/19/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2022
NWAP
NEW APPLICATION ENTERED
07/22/2022
Continuous trademark protection
Get notified about every new filing that threatens LUMABRIDGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.